Cargando…

Antigenicity and immunogenicity of SARS-CoV-2 surface glycoprotein fragment in CHO cells

BACKGROUND AND OBJECTIVES: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) glycoprotein that projects from the virus surface is highly immunogenic. It is considered to be the target of many neutralizing antibodies as well as a target in vaccine design efforts. Evaluation the i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karimi, Sahar, Nazarian, Shahram, Sotoodehnejadnematalahi, Fattah, Dorostkar, Roohollah, Amani, Jafar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tehran University of Medical Sciences 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105267/ https://www.ncbi.nlm.nih.gov/pubmed/37069912 http://dx.doi.org/10.18502/ijm.v15i1.11929

Ejemplares similares

Recombinant expression of SARS-CoV-2 receptor binding domain (RBD) in Escherichia coli and its immunogenicity in mice
por: Rahbar, Zahra, et al.
Publicado: (2022)

Preparation of chitosan nanoparticle containing recombinant StxB antigen of EHEC and evaluation its immunogenicity in BALB/c mice
por: Almasian, Pegah, et al.
Publicado: (2018)

Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells
por: Du, Lanying, et al.
Publicado: (2009)

Immunogenic evaluation of chimeric recombinant protein against ETEC, EHEC and Shigella
por: Khalouie, Farzane, et al.
Publicado: (2017)

Immunogenicity of inactivated Escherichia coli O157:H7 with Stx2B microparticle in mice
por: Arshadi, Nasim, et al.
Publicado: (2022)

Immunogenic Potency of Formalin and Heat Inactivated E. coli O157:H7 in Mouse Model Administered by Different Routes
por: Arshadi, Nasim, et al.
Publicado: (2020)

Immunogenicity of the nanovaccine containing intimin recombinant protein in the BALB/c mice
por: Hosseini, Zahra Sadat, et al.
Publicado: (2018)

Immunogenicity of a Fusion Protein Comprising Coli Surface Antigen 3 and Labile B Subunit of Enterotoxigenic Escherichia coli
por: Alerasol, Masoome, et al.
Publicado: (2014)

Immunogenicity of the Multi-Epitopic Recombinant Glycoproteins of Newcastle Disease Virus: Implications for the Serodiagnosis Applications
por: Motamedi, Mohammad Javad, et al.
Publicado: (2018)

The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens
por: Duan, Liangwei, et al.
Publicado: (2020)

In silico analysis of chimeric espA, eae and tir fragments of Escherichia coli O157:H7 for oral immunogenic applications
por: Amani, Jafar, et al.
Publicado: (2009)

Expression of SARS-CoV-2 surface glycoprotein fragment 319–640 in E. coli, and its refolding and purification
por: Fitzgerald, Gabriel A., et al.
Publicado: (2021)

Immunogenicity and antigenicity of a conserved fragment of the rhoptry-associated membrane antigen of Plasmodium vivax
por: Ge, Jieyun, et al.
Publicado: (2022)

Dual Role of Respiratory Syncytial Virus Glycoprotein Fragment as a Mucosal Immunogen and Chemotactic Adjuvant
por: Kim, Sol, et al.
Publicado: (2012)

Detection of E. coli O157:H7 and Shigella dysenteriae toxins in clinical samples by PCR-ELISA
por: Amani, Jafar, et al.
Publicado: (2015)

Engineering of CHO Cells for the Production of Recombinant Glycoprotein Vaccines with Xylosylated N-glycans
por: Sandig, Grit, et al.
Publicado: (2017)

Construction of the Enterococcal Strain Expressing Immunogenic Fragment of SARS-Cov-2 Virus
por: Suvorov, Alexander, et al.
Publicado: (2022)

Immunogenic Epitope-Based Vaccine Prediction from Surface Glycoprotein of MERS-CoV by Deploying Immunoinformatics Approach
por: Nguyen, Truc Ly, et al.
Publicado: (2022)

Human activated macrophages and hypoxia: a comprehensive review of the literature
por: Sotoodehnejadnematalahi, Fattah, et al.
Publicado: (2014)

In-silico design and evaluation of an epitope-based serotype-independent promising vaccine candidate for highly cross-reactive regions of pneumococcal surface protein A
por: Afshari, Elnaz, et al.
Publicado: (2023)

Immunogenicity and Antigenicity of the Ectodomain of Rabies Virus Glycoprotein Stably Expressed in HEK293T Cells
por: Li, Qingqing, et al.
Publicado: (2023)

Immunogenicity of the spike glycoprotein of Bat SARS-like coronavirus
por: Hou, Yu-xuan, et al.
Publicado: (2010)

Proteomic differences in recombinant CHO cells producing two similar antibody fragments
por: Sommeregger, Wolfgang, et al.
Publicado: (2016)

Expression, purification and identification of an immunogenic fragment in the ectodomain of prostate-specific membrane antigen
por: TAO, RONG, et al.
Publicado: (2016)

Design of a highly thermotolerant, immunogenic SARS-CoV-2 spike fragment
por: Malladi, Sameer Kumar, et al.
Publicado: (2020)

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
por: Walls, Alexandra C., et al.
Publicado: (2020)

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
por: Walls, Alexandra C., et al.
Publicado: (2020)

Presenting a rapid method for detection of Bacillus cereus, Listeria monocytogenes and Campylobacter jejuni in food samples
por: Razei, Ali, et al.
Publicado: (2017)

Rational Design of SARS-CoV-2 Spike Glycoproteins To Increase Immunogenicity By T Cell Epitope Engineering
por: Ong, Edison, et al.
Publicado: (2020)

Computational design of SARS-CoV-2 spike glycoproteins to increase immunogenicity by T cell epitope engineering
por: Ong, Edison, et al.
Publicado: (2020)

Presentation of antigen on extracellular vesicles using transmembrane domains from viral glycoproteins for enhanced immunogenicity
por: Hu, Kai, et al.
Publicado: (2022)

Increased risk of COVID-19 mortality rate in IFITM3 rs6598045 G allele carriers infected by SARS-CoV-2 delta variant
por: Gholami, Melika, et al.
Publicado: (2022)

In silico experiment with an-antigen-toll like receptor-5 agonist fusion construct for immunogenic application to Helicobacter pylori
por: Haghighi, Mohamad Ali, et al.
Publicado: (2013)

SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice
por: Tian, Jing-Hui, et al.
Publicado: (2021)

Data on multiple SARS-CoV-2 surface glycoprotein alignments
por: Stojanov, Done
Publicado: (2021)

In Silico Design of a Chimeric Protein Containing Antigenic Fragments of Helicobacter pylori; A Bioinformatic Approach
por: Mohammad, Nazanin, et al.
Publicado: (2016)

Immunogenicity of Cork and Loop Domains of Recombinant Baumannii acinetobactin Utilization Protein in Murine Model
por: Esmaeilkhani, Hamid, et al.
Publicado: (2019)

Synthetic virions reveal fatty acid-coupled adaptive immunogenicity of SARS-CoV-2 spike glycoprotein
por: Staufer, Oskar, et al.
Publicado: (2022)

Antigenicity and Immunogenicity of Plasmodium vivax Merozoite Surface Protein-3
por: Bitencourt, Amanda R., et al.
Publicado: (2013)

Precise modification of the surface charge of antigen enhances vaccine immunogenicity
por: Zai, Xiaodong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bi5sh1smuqque3v1n9s1e56gnc